Cargando…

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials

Detalles Bibliográficos
Autores principales:	Shankar-Hari, Manu, Estcourt, Lise, Harvala, Heli, Roberts, David, Menon, David K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370253/ https://www.ncbi.nlm.nih.gov/pubmed/32690059 http://dx.doi.org/10.1186/s13054-020-03163-3

Ejemplares similares

Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial
por: Fish, M., et al.
Publicado: (2022)

The Relationship Between SARS-CoV-2 Neutralizing Antibody Titers and Avidity in Plasma Collected From Convalescent Nonvaccinated and Vaccinated Blood Donors
por: Nurmi, Visa, et al.
Publicado: (2023)

Convalescent Plasma for Covid-19 — Making Sense of the Inconsistencies
por: Estcourt, Lise, et al.
Publicado: (2022)

Convalescent plasma for COVID-19: male gender, older age and hospitalisation associated with high neutralising antibody levels, England, 22 April to 12 May 2020
por: Mehew, Jennifer, et al.
Publicado: (2020)

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial
por: Desmarets, Maxime, et al.
Publicado: (2023)

International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
por: Murphy, Michael, et al.
Publicado: (2020)

Convalescent plasma donors show enhanced cross‐reactive neutralizing antibody response to antigenic variants of SARS‐CoV‐2 following immunization
por: Harvala, Heli, et al.
Publicado: (2022)

Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma
por: Nguyen, Dung, et al.
Publicado: (2021)

Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection
por: Ratcliff, Jeremy, et al.
Publicado: (2021)

How should we use convalescent plasma therapies for the management of COVID-19?
por: Wood, Erica M., et al.
Publicado: (2021)

Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020
por: Harvala, Heli, et al.
Publicado: (2020)

Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023)

Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary
por: Wouters, Elise, et al.
Publicado: (2020)

The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
por: Tirnea, Livius, et al.
Publicado: (2021)

Immunological Subpopulations Within Critically Ill COVID-19 Patients
por: Wilson, Julie Kay, et al.
Publicado: (2021)

Comparison of SARS‐CoV‐2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot study
por: Harvala, Heli, et al.
Publicado: (2021)

Compartmentalisation of immune responses in critical illness: does it matter?
por: Conway Morris, Andrew, et al.
Publicado: (2022)

Convalescent plasma therapy for persistent hepatitis E virus infection
por: Ankcorn, Michael, et al.
Publicado: (2019)

CONVALESCENT PLASMA THERAPY IN CRITICALLY ILL PATIENTS WITH LATE STAGE COVID-19
por: Kumar, Neil, et al.
Publicado: (2020)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study
por: Kurtz, Pedro, et al.
Publicado: (2021)

Clinical outcomes of using plasma in COVID-19 convalescent critically ill patients
por: Astola Hidalgo, I., et al.
Publicado: (2023)

What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
por: Miller, Andrew Carl, et al.
Publicado: (2021)

Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial
por: Khamis, Faryal, et al.
Publicado: (2021)

Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile
por: Sturek, Jeffrey M., et al.
Publicado: (2022)

Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID‐19
por: Donzelli, Massimo, et al.
Publicado: (2020)

Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials
por: Santhakumaran, Shalini, et al.
Publicado: (2019)

Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Zhang, Bin, et al.
Publicado: (2020)

Elucidating the pivotal role of convalescent plasma therapy in critically ill COVID-19 patients: A review
por: Richard, Seidu A., et al.
Publicado: (2020)

Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction
por: Lamikanra, Abigail, et al.
Publicado: (2021)

Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
por: Schwartz, Stephanie P., et al.
Publicado: (2020)

Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study
por: Huang, Li, et al.
Publicado: (2021)

Effectiveness of Convalescent Plasma Therapy in Severe or Critically Ill COVID-19 Patients: A Retrospective Cohort Study
por: Cho, YunSuk, et al.
Publicado: (2021)

Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy
por: Semedi, Bambang Pujo, et al.
Publicado: (2022)

In Pursuit of Precision Medicine in the Critically Ill
por: Shankar-Hari, M., et al.
Publicado: (2018)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma
por: Einollahi, Behzad, et al.
Publicado: (2020)

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
por: Harvala, Heli, et al.
Publicado: (2020)

Convalescent plasma therapy in COVID-19 critically ill patients during advanced phases of clinical trials and their preliminary results
por: de Oliveira, Fernando Anselmo, et al.
Publicado: (2021)

The Efficiency of Convalescent Plasma Therapy in the Management of Critically Ill Patients Infected With COVID-19: A Matched Cohort Study
por: Pan, Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r4crsunaiuq7gbdkke9llglnh5